Document:

Exhibit

Exhibit 4.8
DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
The following description of the common stock of TransEnterix, Inc. (“us,” “our,” “we,” or the “Company”), which is the only security of the Company registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our amended and restated certificate of incorporation, as amended, including by the Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock (the “Certificate of Designation, and with the amended and restated certificate of incorporation, as amended the “Certificate of Incorporation”) and amended and restated by-laws (“Bylaws”), which are incorporated as exhibits to this Annual Report on Form 10-K and are incorporated herein by reference herein. We encourage you to read our Certificate of Incorporation, our Bylaws, and the applicable provisions of the Delaware general corporate law for additional information.
Authorized Shares of Capital Stock
Our authorized capital stock consists of 750,000,000 shares of common stock, par value $0.001 per share (the “Common Stock”), and 25,000,000 shares of preferred stock, par value $0.01 per share (the “Preferred Stock”).
As of March 12, 2020, there were 46,089,766 shares of Common Stock issued and outstanding and 5,675,293 shares of Series A Convertible Preferred Stock (the “Series A Preferred”) issued and outstanding. All of the shares of the Common Stock currently issued and outstanding are fully-paid and non-assessable.
Common Stock
Listing
The Common Stock is listed on the NYSE American under the symbol “TRXC.”
Dividend Rights
Subject to the prior rights of the holders of any shares of Preferred Stock which may be issued in the future, the holders of the Common Stock are entitled to receive dividends from our funds legally available therefor when, as and if declared by our Board of Directors (“Board”). The Series A Preferred is entitled to dividends only if declared and paid on the Common Stock.
Voting Rights
Holders of the Common Stock are entitled to one vote per share on all matters which they are entitled to vote upon at meetings of stockholders or upon actions taken by written consent pursuant to Delaware corporate law. The holders of the Common Stock do not have cumulative voting rights, which mean that the holders of a plurality of the outstanding shares of Common Stock can elect all of our directors. 
Liquidation and Dissolution
In the event of our liquidation, dissolution or winding-up, the holders of the Common Stock are entitled to share ratably in all of our assets available for distribution to holders of the Common Stock, subject to the liquidation preferences, if any, of any then-outstanding Preferred Stock.  The holders of Series A Preferred will be treated equally with the holders of Common Stock in any liquidation, dissolution or winding-up of the Company.
No Preemptive or Similar Rights
Holders of the Common Stock do not have any preemptive, subscription, redemption or conversion rights.
Transfer Agent
The transfer agent for the Common Stock is Continental Stock Transfer & Trust Company.
Relationship to Preferred Stock
The Board has the authority, without further action by the holders of the outstanding Common Stock, to issue Preferred Stock from time to time in one or more classes or series, to fix the number of shares constituting any class or series and the stated value thereof, if different from the par value, as to fix the terms of any such series or class, including dividend rights, dividend rates, conversion or exchange rights, voting rights, rights and terms of redemption (including sinking fund provisions), the redemption price and the liquidation preference of such class or series.  Any or all of these rights may be greater than the rights of our Common Stock. Our Board may authorize the issuance of Preferred Stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our Common Stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation.  The Certificate of Designation sets fort the rights of the Series A Preferred.  
Registration Rights
We entered into a Registration Rights Agreement, dated February 10, 2020 (the “Registration Rights Agreement”), with Lincoln Park Capital Fund (“LPC”), pursuant to which we agreed to file a prospectus supplement to register for resale the shares of Common Stock held by LPC.  Under the terms of the Registration Rights Agreement, we are required to use commercially reasonable efforts to keep the registration statement and prospectus current and available for the resale of all of the shares of Common Stock held by LPC at all times for up to a possible maximum of forty-two months.

Anti-Takeover Effects of Certain Provisions of our Certificate of Incorporation, our Bylaws and Delaware Law
Delaware Statute
We are subject to Section 203 of the Delaware General Corporation Law, which prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years after the date of the transaction in which the person became an interested stockholder, unless:
		
	•
	prior to such date, our Board approves either the business combination or the transaction that resulted in the stockholder’s becoming an interested stockholder;

		
	•
	upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owns at least 85% of our outstanding voting stock, excluding shares held by directors, officers and certain employee stock plans; or

		
	•
	on or after the consummation date, the business combination is approved by our Board and by the affirmative vote at an annual or special meeting of stockholders holding at least two-thirds of our outstanding voting stock that is not owned by the interested stockholder.

For purposes of Section 203, a “business combination” includes, among other things, a merger, asset sale or other transaction resulting in a financial benefit to the interested stockholder, and an “interested stockholder” is generally a person who, together with affiliates and associates of such person:
		
	•
	owns 15% or more of outstanding voting stock; or

		
	•
	is an affiliate or associate of ours and was the owner of 15% or more of our outstanding voting stock at any time within the prior three years.

Certificate of Incorporation and Bylaw Provisions
Our Certificate of Incorporation and Bylaws include provisions that, among others, could have the effect of delaying, deferring or discouraging potential acquisition proposals and could delay or prevent a change of control of the Company. The provisions in our Certificate of Incorporation and Bylaws that may have such effect include:
		
	•
	Preferred Stock. As noted above, our Board, without stockholder approval, has the authority under our certificate of incorporation to issue Preferred Stock with rights superior to the rights of the holders of the Common Stock. As a result, we could issue Preferred Stock quickly and easily, which could adversely affect the rights of holders of the Common Stock and could be issued with terms calculated to delay or prevent a change of control or make removal of management more difficult.

		
	•
	Stockholder Meetings. Under our Certificate of Amendment and Bylaws, special meetings of our stockholders may be called only by the vote of a majority of the entire Board or the chairman of the Board. Our stockholders may not call a special meeting of the stockholders.

		
	•
	Requirements for Advance Notification of Stockholder Nominations and Proposals. Our Bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of our Board or a committee thereof.Exhibit 4.3

 

DESCRIPTION OF SECURITIES

 

When used herein, the terms “we,”
 “our,” “the Company,” and “us” refer to Fortress Biotech, Inc. 

 

DESCRIPTION OF CAPITAL STOCK

 

The following summary
of the terms of our common stock may not be complete and is subject to, and qualified in its entirety by reference to, the terms
and provisions of our amended and restated certificate of incorporation and our amended and restated bylaws. You should refer to,
and read this summary together with, our amended and restated certificate of incorporation and restated bylaws to review all of
the terms of our common stock that may be important to you.

 

Common Stock

 

The Company’s
certificate of incorporation, as amended, authorizes the Company to issue up to 100,000,000 shares of $0.001 par value common stock
(“Common Stock”). Our Common Stock is traded on The Nasdaq Capital Market under the symbol “FBIO.”

 

The terms, rights, preference
and privileges of the Common Stock are as follows:

 

Voting Rights

Each holder of Common
Stock is entitled to one vote per share of Common Stock held on all matters submitted to a vote of the stockholders, including
the election of directors. The Company’s certificate of incorporation and bylaws do not provide for cumulative voting rights.

 

Dividends

Subject to preferences
that may be applicable to any then-outstanding preferred stock, the holders of the Company’s outstanding shares of Common
Stock are entitled to receive dividends, if any, as may be declared from time to time by the Company’s Board of Directors
out of legally available funds.

 

Liquidation

In the event of the
Company’s liquidation, dissolution or winding up, holders of Common Stock will be entitled to share ratably in the net assets
legally available for distribution to stockholders after the payment of all of the Company’s debts and other liabilities,
subject to the satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock.

 

Rights and Preference

Holders of the Company’s
Common Stock have no preemptive, conversion or subscription rights, and there is no redemption or sinking fund provisions applicable
to our Common Stock. The rights, preferences and privileges of the holders of Common Stock are subject to, and may be adversely
affected by, the rights of the holders of shares of any series of the Company’s preferred stock that are or may be issued.

 

Fully Paid and Nonassessable

All of the Company’s
outstanding shares of Common Stock are fully paid and nonassessable.

 

Preferred Stock

 

Under the terms of our
amended and restated certificate of incorporation, our board of directors is authorized to issue up to 15,000,000 shares of preferred
stock, par value $0.001 per share. Our board of directors may issue shares of preferred stock in one or more series without stockholder
approval, and has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend
rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. We may amend from
time to time our amended and restated certificate of incorporation to increase the number of authorized shares of preferred stock.
Any such amendment would require the approval of the holders of a majority of the voting power of the shares entitled to vote thereon.
As of the current date, we have 15,000,000 shares of preferred shares authorized, which includes the 5,000,000 shares of our Series
A Preferred Stock (as defined below). At present, 2,059,917 shares of our Series A Preferred Stock are issued and outstanding.
No other classes of preferred stock have been designated or issued at this time.

 

     

     

    

 

It is not possible
to state the actual effect of the issuance of any shares of preferred stock upon the rights of the holders of common stock until
the board of directors determines the specific rights of the holders of preferred stock. However, effects of the issuance of preferred
stock include restricting dividends on common stock, diluting the voting power of common stock, impairing the liquidation rights
of common stock, and making it more difficult for a third party to acquire us, which could have the effect of discouraging a third
party from acquiring, or deterring a third party from paying a premium to acquire, a majority of our outstanding voting stock.

 

The particular terms
of any series of preferred stock being offered by us will be described in the applicable prospectus supplement or similar offering
documentation relating to that series of preferred stock. Those terms may include:

 

		·	the title and liquidation preference per share of
the preferred stock and the number of shares offered;

 

		·	the purchase price of the preferred stock;

 

		·	the dividend rate (or method of calculation);

 

		·	the dates on which dividends will be paid and the
date from which dividends will begin to accumulate;

 

		·	any redemption or sinking fund provisions of the preferred
stock;

 

		·	any listing of the preferred stock on any securities
exchange or market;

 

		·	any conversion provisions of the preferred stock;

 

		·	the voting rights, if any, of the preferred stock;
and

 

		·	any additional dividend, liquidation, redemption,
sinking fund and other rights, preferences, privileges, limitations and restrictions of the preferred stock.

 

The preferred stock
will, when issued, be fully paid and non-assessable.

 

Series A Preferred Stock

 

On October 26, 2017,
the Company designated 5,000,000 shares of preferred stock as Series A Preferred Stock (“Series A Preferred Stock”).
Our Series A Preferred Stock is traded on The Nasdaq Capital Market under the symbol “FBIOP.”

 

The terms, rights, preference
and privileges of the Series A Preferred Stock are as follows:

 

Voting
Rights

Except
as may be otherwise required by law, the voting rights of the holders of the Series A Preferred Stock are limited to the affirmative
vote or consent of the holders of at least two-thirds of the votes entitled to be cast by the holders of the Series A Preferred
Stock outstanding at the time in connection with the: (1) authorization or creation, or increase in the authorized or issued amount
of, any class or series of capital stock ranking senior to the Series A Preferred Stock with respect to payment of dividends or
the distribution of assets upon liquidation, dissolution or winding up or reclassification of any of the Company’s authorized
capital stock into such shares, or creation, authorization or issuance of any obligation or security convertible into or evidencing
the right to purchase any such shares; or (2) amendment, alteration, repeal or replacement of the Company’s certificate
of incorporation, including by way of a merger, consolidation or otherwise in which the Company may or may not be the surviving
entity, so as to materially and adversely affect and deprive holders of Series A Preferred Stock of any right, preference, privilege
or voting power of the Series A Preferred Stock.

 

    2

     

    

 

Dividends 

Dividends on Series
A Preferred Stock accrue daily and will be cumulative from, and including, the date of original issue and shall be payable quarterly
every March 31, June 30, September 30, and December 31, at the rate of 9.375% per annum of its liquidation preference, which is
equivalent to $2.34375 per annum per share. The first dividend on Series A Preferred Stock was payable on December 31, 2017 (in
the amount of $0.299479 per share) to the holders of record of the Series A Preferred Stock at the close of business on
December 15, 2017.

 

No Maturity Date
or Mandatory Redemption 

The Series A Preferred
Stock has no maturity date, and the Company is not required to redeem the Series A Preferred Stock. Accordingly, the Series A Preferred
Stock will remain outstanding indefinitely unless the Company decides to redeem it pursuant to its optional redemption right or
its special optional redemption right in connection with a Change of Control (as defined below), or under the circumstances set
forth below under “Limited Conversion Rights Upon a Change of Control” and elect to convert such Series A Preferred
Stock. The Company is not required to set aside funds to redeem the Series A Preferred Stock.

 

Optional Redemption

The Series A Preferred
Stock may be redeemed in whole or in part (at the Company’s option) any time on or after December 15, 2022, upon not less
than 30 days nor more than 60 days’ written notice by mail prior to the date fixed for redemption thereof, for cash at a
redemption price equal to $25.00 per share, plus any accumulated and unpaid dividends to, but not including, the redemption date.

 

Special Optional
Redemption 

Upon the occurrence
a Change of Control (as defined below), the Company may redeem the shares of Series A Preferred Stock, at its option, in whole
or in part, within one hundred twenty (120) days of any such Change of Control, for cash at $25.00 per share, plus accumulated
and unpaid dividends (whether or not declared) to, but excluding, the redemption date. If, prior to the Change of Control conversion
date, the Company has provided notice of its election to redeem some or all of the shares of Series A Preferred Stock (whether
pursuant to the Company’s optional redemption right described above under “Optional Redemption” or this special
optional redemption right), the holders of shares of Series A Preferred Stock will not have the Change of Control conversion right
with respect to the shares of Series A Preferred Stock called for redemption. If the Company elects to redeem any shares of the
Series A Preferred Stock as described in this paragraph, the Company may use any available cash to pay the redemption price.

 

A “Change of Control”
is deemed to occur when, after the original issuance of the Series A Preferred Stock, the following have occurred and are continuing:

 

		·	the acquisition by any person, including any syndicate
or group deemed to be a “person” under Section 13(d)(3) of the Exchange Act of beneficial ownership, directly or indirectly,
through a purchase, merger or other acquisition transaction or series of purchases, mergers or other acquisition transactions
of the Company’s stock entitling that person to exercise more than 50% of the total voting power of all the Company’s
stock entitled to vote generally in the election of the Company’s directors (except that such person will be deemed to have
beneficial ownership of all securities that such person has the right to acquire, whether such right is currently exercisable
or is exercisable only upon the occurrence of a subsequent condition); and

 

		·	following the closing of any transaction referred
to in the bullet point above, neither the Company nor the acquiring or surviving entity has a class of common equity securities
(or American Depositary Receipts representing such securities) listed on the NYSE, the NYSE American LLC or the Nasdaq Stock Market,
or listed or quoted on an exchange or quotation system that is a successor to the NYSE, the NYSE American LLC or the Nasdaq Stock
Market.

 

Conversion, Exchange
and Preemptive Rights 

Except as described
below under “Limited Conversion Rights upon a Change of Control,” the Series A Preferred Stock is not subject to preemptive
rights or convertible into or exchangeable for any other securities or property at the option of the holder.

 

    3

     

    

 

Limited Conversion
Rights upon a Change of Control 

Upon the occurrence
of a Change of Control, each holder of shares of Series A Preferred Stock will have the right (unless, prior to the Change of Control
Conversion Date, the Company has provided or provides irrevocable notice of its election to redeem the Series A Preferred Stock
as described above under “Optional Redemption,” or “Special Optional Redemption”) to convert some or all
of the shares of Series A Preferred Stock held by such holder on the Change of Control Conversion Date, into the Common Stock Conversion
Consideration, which is equal to the lesser of:

 

		·	the quotient obtained by dividing (i) the sum of the
$25.00 liquidation preference per share of Series A Preferred Stock plus the amount of any accumulated and unpaid dividends (whether
or not declared) to, but not including, the Change of Control Conversion Date (unless the Change of Control Conversion Date is
after a record date for a Series A Preferred Stock dividend payment and prior to the corresponding Dividend Payment Date, in which
case no additional amount for such accumulated and unpaid dividend will be included in this sum) by (ii) the Common Stock Price
(such quotient, the “Conversion Rate”); and

 

		·	13.05483 shares of common stock, subject to certain
adjustments.

 

In the case of a Change
of Control pursuant to which the Company’s common stock will be converted into cash, securities or other property or assets,
a holder of Series A Preferred Stock will receive upon conversion of such Series A Preferred Stock the kind and amount of Alternative
Form Consideration which such holder would have owned or been entitled to receive upon the Change of Control had such holder held
a number of shares of the Company’s common stock equal to the Common Stock Conversion Consideration immediately prior to
the effective time of the Change of Control.

 

Notwithstanding the
foregoing, the holders of shares of Series A Preferred Stock will not have the Change of Control Conversion Right if the acquiror
has shares listed or quoted on the NYSE, the NYSE American LLC or Nasdaq Stock Market or listed or quoted on an exchange or quotation
system that is a successor to the NYSE, the NYSE American LLC or Nasdaq Stock Market, and the Series A Preferred Stock becomes
convertible into or exchangeable for such acquiror’s listed shares upon a subsequent Change of Control of the acquiror.

 

Liquidation Preference

In the event the Company
liquidates, dissolves or is wound up, holders of the Series A Preferred Stock will have the right to receive $25.00 per share,
plus any accumulated and unpaid dividends to, but not including, the date of payment, before any payment is made to the holders
of the Company’s Common Stock.

 

Ranking

The Series A Preferred
Stock will rank, with respect to rights to the payment of dividends and the distribution of assets upon the Company’s liquidation,
dissolution or winding up, (1) senior to all classes or series of the Company’s Common Stock and to all other equity securities
issued by the Company other than equity securities referred to in clauses (2) and (3); (2) on a par with all equity securities
issued by the Company with terms specifically providing that those equity securities rank on a par with the Series A Preferred
Stock with respect to rights to the payment of dividends and the distribution of assets upon the Company’s liquidation, dissolution
or winding up; (3) junior to all equity securities issued by the Company with terms specifically providing that those equity securities
rank senior to the Series A Preferred Stock with respect to rights to the payment of dividends and the distribution of assets upon
the Company liquidation, dissolution or winding up; and (4) junior to all of the Company’s existing and future indebtedness.

 

Transfer Agent

 

VStock Transfer, LLC
serves as the transfer agent and registrar for all of our Common Stock and Series A Preferred Stock.

 

    4

     

    

 

DESCRIPTION OF WARRANTS

 

We may issue warrants
to purchase shares of our Common Stock and/or preferred stock in one or more series together with other securities or separately,
as described in each applicable prospectus supplement or similar offering documentation.

 

The prospectus supplement
or similar offering documentation relating to any warrants we offer will include specific terms relating to the offering. These
terms will include some or all of the following:

 

		·	the title of the warrants;

 

		·	the aggregate number of warrants offered;

 

		·	the designation, number and terms of the shares of
Common Stock purchasable upon exercise of the warrants and procedures by which those numbers may be adjusted;

 

		·	the exercise price of the warrants;

 

		·	the dates or periods during which the warrants are
exercisable;

 

		·	the designation and terms of any securities with which
the warrants are issued;

 

		·	if the warrants are issued as a unit with another
security, the date on and after which the warrants and the other security will be separately transferable;

 

		·	if the exercise price is not payable in U.S. dollars,
the foreign currency, currency unit or composite currency in which the exercise price is denominated;

 

		·	any minimum or maximum amount of warrants that may
be exercised at any one time;

 

		·	any terms relating to the modification of the warrants;

 

		·	any terms, procedures and limitations relating to
the transferability, exchange or exercise of the warrants; and

 

		·	any other specific terms of the warrants.

 

DESCRIPTION OF DEBT SECURITIES

 

We may offer debt securities
which may be senior, subordinated or junior subordinated and may be convertible. Unless otherwise specified in the applicable prospectus
supplement or similar offering documentation, our debt securities will be issued in one or more series under an indenture to be
entered into between us and a trustee. We will issue the debt securities under an indenture to be entered into between us and the
trustee identified in the applicable prospectus supplement or similar offering documentation. The terms of the debt securities
will include those stated in the indenture and those made part of the indenture by reference to the Trust Indenture Act of 1939,
as in effect on the date of the indenture. We have filed a copy of the form of indenture as an exhibit to this annual report on
Form 10-K. The indenture will be subject to and governed by the terms of the Trust Indenture Act of 1939.

 

The following description
briefly sets forth certain general terms and provisions of the debt securities that we may offer. The particular terms of the debt
securities and the extent, if any, to which general provisions may apply to the debt securities, will be described in the related
prospectus supplement or similar offering documentation. Accordingly, for a description of the terms of a particular issue of debt
securities, reference must be made to both the related prospectus supplement or similar offering documentation and to the following
description.

 

    5

     

    

 

The aggregate principal
amount of debt securities that may be issued under the indenture is unlimited. The debt securities may be issued in one or more
series as may be authorized from time to time pursuant to a supplemental indenture entered into between us and the trustee or an
order delivered by us to the trustee. For each series of debt securities we offer, a prospectus supplement or similar offering
documentation will describe the following terms and conditions of the series of debt securities that we are offering, to the extent
applicable:

 

		·	title and aggregate principal amount;

 

		·	whether the debt securities will be senior, subordinated
or junior subordinated;

 

		·	applicable subordination provisions, if any;

 

		·	provisions regarding whether the debt securities will
be convertible or exchangeable into other securities or property of the Company or any other person;

 

		·	percentage or percentages of principal amount at which
the debt securities will be issued;

 

		·	maturity date(s);

 

		·	interest rate(s) or the method for determining the
interest rate(s);

 

		·	whether interest on the debt securities will be payable
in cash or additional debt securities of the same series;

 

		·	dates on which interest will accrue or the method
for determining dates on which interest will accrue and dates on which interest will be payable;

 

		·	whether the amount of payment of principal of, premium,
if any, or interest on the debt securities may be determined with reference to an index, formula or other method;

 

		·	redemption, repurchase or early repayment provisions,
including our obligation or right to redeem, purchase or repay debt securities under a sinking fund, amortization or analogous
provision;

 

		·	if other than the debt securities’ principal
amount, the portion of the principal amount of the debt securities that will be payable upon declaration of acceleration of the
maturity;

 

		·	authorized denominations;

 

		·	form;

 

		·	amount of discount or premium, if any, with which
the debt securities will be issued, including whether the debt securities will be issued as “original issue discount”
securities;

 

		·	the place or places where the principal of, premium,
if any, and interest on the debt securities will be payable;

 

		·	where the debt securities may be presented for registration
of transfer, exchange or conversion;

 

		·	the place or places where notices and demands to or
upon the Company in respect of the debt securities may be made;

 

		·	whether the debt securities will be issued in whole
or in part in the form of one or more global securities;

 

    6

     

    

 

		·	if the debt securities will be issued in whole or
in part in the form of a book-entry security, the depository or its nominee with respect to the debt securities and the circumstances
under which the book-entry security may be registered for transfer or exchange or authenticated and delivered in the name of a
person other than the depository or its nominee;

 

		·	whether a temporary security is to be issued with
respect to such series and whether any interest payable prior to the issuance of definitive securities of the series will be credited
to the account of the persons entitled thereto;

 

		·	the terms upon which beneficial interests in a temporary
global security may be exchanged in whole or in part for beneficial interests in a definitive global security or for individual
definitive securities;

 

		·	the guarantors, if any, of the debt securities, and
the extent of the guarantees and any additions or changes to permit or facilitate guarantees of such debt securities;

 

		·	any covenants applicable to the particular debt securities
being issued;

 

		·	any defaults and events of default applicable to the
debt securities, including the remedies available in connection therewith;

 

		·	currency, currencies or currency units in which the
purchase price for, the principal of and any premium and any interest on, such debt securities will be payable;

 

		·	time period within which, the manner in which and
the terms and conditions upon which the Company or the purchaser of the debt securities can select the payment currency;

 

		·	securities exchange(s) on which the debt securities
will be listed, if any;

 

		·	whether any underwriter(s) will act as market maker(s)
for the debt securities;

 

		·	extent to which a secondary market for the debt securities
is expected to develop;

 

		·	provisions relating to defeasance;

 

		·	provisions relating to satisfaction and discharge
of the indenture;

 

		·	any restrictions or conditions on the transferability
of the debt securities;

 

		·	provisions relating to the modification of the indenture
both with and without the consent of holders of debt securities issued under the indenture;

 

		·	any addition or change in the provisions related to
compensation and reimbursement of the trustee;

 

		·	provisions, if any, granting special rights to holders
upon the occurrence of specified events;

 

		·	whether the debt securities will be secured or unsecured,
and, if secured, the terms upon which the debt securities will be secured and any other additions or changes relating to such
security; and

 

		·	any other terms of the debt securities that are not
inconsistent with the provisions of the Trust Indenture Act (but may modify, amend, supplement or delete any of the terms of the
indenture with respect to such series of debt securities).

 

    7

     

    

 

General

 

One or more series of
debt securities may be sold as “original issue discount” securities. These debt securities would be sold at a substantial
discount below their stated principal amount, bearing no interest or interest at a rate which at the time of issuance is below
market rates. One or more series of debt securities may be variable rate debt securities that may be exchanged for fixed rate debt
securities.

 

United States federal
income tax consequences and special considerations, if any, applicable to any such series will be described in the applicable prospectus
supplement or similar offering documentation.

 

Debt securities may
be issued where the amount of principal and/or interest payable is determined by reference to one or more currency exchange rates,
commodity prices, equity indices or other factors. Holders of such debt securities may receive a principal amount or a payment
of interest that is greater than or less than the amount of principal or interest otherwise payable on such dates, depending upon
the value of the applicable currencies, commodities, equity indices or other factors. Information as to the methods for determining
the amount of principal or interest, if any, payable on any date, the currencies, commodities, equity indices or other factors
to which the amount payable on such date is linked and certain additional United States federal income tax considerations will
be set forth in the applicable prospectus supplement or similar offering documentation.

 

The term “debt
securities” includes debt securities denominated in U.S. dollars or, if specified in the applicable prospectus supplement
or similar offering documentation, in any other freely transferable currency or units based on or relating to foreign currencies.

 

We expect most debt
securities to be issued in fully registered form without coupons and in denominations of $1,000 and any integral multiples thereof.
Subject to the limitations provided in the indenture and in the prospectus supplement or similar offering documentation, debt securities
that are issued in registered form may be transferred or exchanged at the principal corporate trust office of the trustee, without
the payment of any service charge, other than any tax or other governmental charge payable in connection therewith.

 

Global Securities

 

The debt securities
of a series may be issued in whole or in part in the form of one or more global securities that will be deposited with, or on behalf
of, a depositary identified in the prospectus supplement or similar offering documentation. Global securities will be issued in
registered form and in either temporary or definitive form. Unless and until it is exchanged in whole or in part for the individual
debt securities, a global security may not be transferred except as a whole by the depositary for such global security to a nominee
of such depositary or by a nominee of such depositary to such depositary or another nominee of such depositary or by such depositary
or any such nominee to a successor of such depositary or a nominee of such successor. The specific terms of the depositary arrangement
with respect to any debt securities of a series and the rights of and limitations upon owners of beneficial interests in a global
security will be described in the applicable prospectus supplement or similar offering documentation.

 

Governing Law

 

The indenture and the
debt securities shall be construed in accordance with and governed by the laws of the State of New York.

 

DESCRIPTION OF UNITS

 

We may issue, in one
more series, units comprised of shares of our Common Stock, Series A Preferred Stock or preferred stock, warrants to purchase Common
Stock, Series A Preferred Stock or preferred stock, debt securities or any combination of those securities. Each unit will be issued
so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the
rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that
the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date.

 

    8

     

    

 

We may evidence units
by unit certificates that we issue under a separate agreement. We may issue the units under a unit agreement between us and one
or more unit agents. If we elect to enter into a unit agreement with a unit agent, the unit agent will act solely as our agent
in connection with the units and will not assume any obligation or relationship of agency or trust for or with any registered holders
of units or beneficial owners of units. We will indicate the name and address and other information regarding the unit agent in
the applicable prospectus supplement or similar offering documentation relating to a particular series of units if we elect to
use a unit agent.

 

We will describe in
the applicable prospectus supplement or similar offering documentation the terms of the series of units being offered, including:

 

		·	the designation and terms of the units and of the
securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;

 

		·	any provisions of the governing unit agreement that
differ from those described herein; and

 

		·	any provisions for the issuance, payment, settlement,
transfer or exchange of the units or of the securities comprising the units.

 

The
other provisions regarding our Common Stock, Series A Preferred Stock, preferred stock, warrants and debt securities as described
in this section will apply to each unit to the extent such unit consists of shares of our Common Stock, preferred stock, warrants
and/or debt securities.

 

    9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}]]